List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 54 studies with search of: "Monoamine Oxidase Inhibitor"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Suspended EmSam in Bipolar Depression
Condition: Bipolar Depression
Intervention: Drug: EmSam
2 Completed Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
Condition: Clozapine-induced Hypersalivation
Intervention: Drug: Amisulpride, Tiapride, Moclobemide
3 Recruiting PET Biomarkers in Treatment Resistant Depression
Condition: Major Depressive Disorder
Intervention: Drug: tranylcypromine
4 Recruiting Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
Condition: Idiopathic Parkinson's Disease
Intervention: Drug: Safinamide
5 Active, not recruiting SSRI Effects on Semen Parameters in Men
Condition: Healthy
Intervention: Drug: paroxetine
6 Completed Pharmacological Modulation of Cocaine Effects - 1
Condition: Cocaine-Related Disorders
Intervention: Drug: Selegiline
7 Active, not recruiting A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rasagiline Mesylate
8 Enrolling by invitation Azilect + Antidepressant Chart Review
Condition: Serotonin Syndrome
Interventions: Drug: Group R+AD Rasagiline + Antidepressant;   Drug: Group R Rasagiline;   Drug: Group AD Anti-PD + Antidepressant
9 Active, not recruiting Usefulness of Selegiline as an Aid to Quit Smoking - 1
Condition: Tobacco Use Cessation
Intervention: Drug: Selegiline
10 Completed Selegiline for Smoking Cessation - 1
Condition: Nicotine Dependence
Intervention: Drug: Selegiline
11 Recruiting The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: placebo;   Drug: rasagiline
12 Completed PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly
Condition: Healthy
Interventions: Drug: EMSAM (Selegiline Transdermal System) 6mg;   Drug: EMSAM (Selegiline Transdermal System) 12mg
13 Completed Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
Condition: Marijuana Abuse
Interventions: Drug: Selegiline hydrochloride;   Drug: Placebo
14 Active, not recruiting Testing a Full Substitution Therapy Approach As Treatment of Tobacco Dependence
Condition: Nicotine Dependence
Interventions: Drug: Selegiline + nicotine replacement therapy;   Drug: placebo + nicotine replacement therapy
15 Completed A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
Condition: Parkinson's Disease
Interventions: Drug: rasagiline mesylate;   Other: tyramine
16 Recruiting Rasagiline and Apathy in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rasagiline
17 Completed Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
Condition: Depression
Interventions: Drug: citalopram;   Drug: BuproprionSR;   Drug: buspirone;   Drug: Lithium;   Drug: mirtazapine;   Drug: nortriptyline;   Drug: sertraline;   Drug: tranylcypromine;   Drug: VenlafaxineXR;   Behavioral: Cognitive Therapy;   Drug: T3 (Triiodothyronine)
18 Completed Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
Condition: Cocaine-Related Disorders
Intervention: Drug: Selegiline
19 Terminated Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease
Condition: Early-stage Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Pramipexole
20 Recruiting A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services